How did they manage to get this marked price sensitive?
To me it looks like there's been largely no progress. It sort of reads like they're scrambling to put anything out to the market, (even if it means confirming they still don't have actual results), and the results they do have say:
"Assays have been returned for 60 of the samples collected, with no significant results reported"
